These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12669559)

  • 21. [The transport-trophic support of myocardial function in the modelling of chronic ischemic heart disease].
    Gavrish AS; Rudnitskaia OG; Blagodarov VN
    Lik Sprava; 1997; (4):53-60. PubMed ID: 9471376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The pharmacological and laser correction of disorders of the blood microcirculatory bed in myocardial ischemia].
    Ruzov VI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):5-7. PubMed ID: 9036673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endothelium of myocardium microvessel under conditions of hypothermia, ischemia, reperfusion and pharmaco-cold cardioplegia with calcium antagonist].
    Kazanskaia GM; Volkov AM; D'iakonitsa TM; Zhdanov GP
    Tsitologiia; 2005; 47(1):5-13. PubMed ID: 16602237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioprotective activity of iron oxide nanoparticles.
    Xiong F; Wang H; Feng Y; Li Y; Hua X; Pang X; Zhang S; Song L; Zhang Y; Gu N
    Sci Rep; 2015 Feb; 5():8579. PubMed ID: 25716309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental substantiation for the application of calcium channel blockers in vibration disease].
    Vorob'eva VV; Shabanov PD
    Med Tr Prom Ekol; 2013; (2):37-41. PubMed ID: 23785817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective aspects of calcium antagonists.
    Nayler WG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S10-4. PubMed ID: 1725910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium accumulating ability of various membrane structures of the myocardium in experimental coronary insufficiency].
    Mkhitarian LS
    Ukr Biokhim Zh (1978); 1984; 56(1):78-81. PubMed ID: 6231753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
    Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
    Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of La3+ on the systems providing contractility of vertebrate myocardium].
    Shemarova IV; Korotkov SM; Nesterov VP
    Zh Evol Biokhim Fiziol; 2013; 49(4):285-9. PubMed ID: 24459862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY; Sandmann S; Meissner A; Unger T; Simon R
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A morphofunctional analysis of the early changes in cardiomyocyte structure and metabolism in acute coronary failure].
    Havrysh OS; Kononchuk MA; Verbyts'kyĭ VV
    Fiziol Zh (1994); 1999; 45(3):52-60. PubMed ID: 10439291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Action of dibunol, isoptin and their combination in transitory myocardial ischemia in waking rabbits].
    Koniurev EA
    Farmakol Toksikol; 1987; 50(1):61-4. PubMed ID: 3556553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibition of calmodulin prevents spasms in autologous arterial bypass grafts during surgical treatment of ischemic heart disease].
    Afanas'ev SA; Kozlov BN; Korovin NV; Shipulin VM
    Fiziol Cheloveka; 2006; 32(6):38-41. PubMed ID: 17180889
    [No Abstract]   [Full Text] [Related]  

  • 34. [Morphofunctional principles of myocardial heterogeneity in acute coronary failure].
    Verbyts'kyĭ VV
    Lik Sprava; 2003; (5-6):70-3. PubMed ID: 14618810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium entry blockers and myocardial function.
    Nayler WG; Grinwald P
    Fed Proc; 1981 Dec; 40(14):2855-61. PubMed ID: 6273237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reperfusion injury in ischemic myocardium: effects of nifedipine and verapamil.
    Mrak RE; Carry MM; Murphy ML; Peng CF; Straub KD
    Am J Cardiovasc Pathol; 1990; 3(1):61-8. PubMed ID: 2331362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of calcium antagonists on energy and substrate metabolism during ischemia and reperfusion in hypertensive myocardial hypertrophy.
    Buser PT; Wagner S; Wu S; Higgins CB; Wikman-Coffelt J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S87-92. PubMed ID: 1725012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structural changes in the myocardium in experimental acute coronary insufficiency and as affected by pharmacological agents].
    Tereshchenko VP
    Vrach Delo; 1984 Jul; (7):58-60. PubMed ID: 6475022
    [No Abstract]   [Full Text] [Related]  

  • 40. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.